We have found that a malignant mesothelioma cell line, NCI-H28, had a chromosome 3p21.3 homozygous deletion containing the b-catenin gene (CTNNB1), which suggested that the deletion of b-catenin might have a growth advantage in the development of this tumor. To determine whether b-catenin has a growth-inhibitory activity, we transfected wild-type b-catenin, Ser37Cys mutant b-catenin as an activated type, and C-terminus deletion mutant b-catenin that lacks the transcription activity, into the NCI-H28 cells. A non-small cell lung cancer cell line, NCI-H1299, which expressed endogenous b-catenin, was also studied. We tested the localization of exogenous b-catenin in the NCI-H28 cells with immunofluorescence, and found that the wild-type b-catenin and the C-terminus deletion mutant were more strongly expressed in the plasma membrane and cytoplasm than in the nucleus, while the Ser37Cys mutant was more in the nucleus than in the cytoplasm. By using luciferasereporter assay, the b-catenin/T-cell factor 4-mediated transactivity of the Ser37Cys mutant was shown to be higher than that of the wild-type b-catenin in both cell lines. However, the transactivity of the C-terminus deletion mutant was strongly reduced in both. Colony formation of the NCI-H28 cells was reduced by 50% after transfection with the wild-type b-catenin, and 60% with the Ser37Cys mutant, but only 20% with the C-terminus deletion mutant compared to the vector control. Inhibition of colony formation in NCI-H28 cells was because of apoptosis, manifested by positive staining of Annexin V and TUNEL assays in transfected cells. In contrast, when transfected with the wild-type b-catenin, no significant reduction in colony formation was seen in b-catenin wildtype NCI-H1299 cells. In conclusion, our data indicate that inactivation of b-catenin by a 3p21.3 homozygous deletion might be a crucial event in the development of the mesothelioma NCI-H28 cells. Thus, while b-catenin is well known to be a positive growth-stimulating factor for many human cancers, it can also act as a potential growth suppressor in some types of human cancer cells.
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Introduction
The Wnt signaling pathway plays a critical role in organogenesis and carcinogenesis, and consists of several components including b-catenin, which acts as a transcription factor or a cell adhesion molecule coupled with cadherins (Barth et al., 1997) . In the presence of Wnt signaling, free b-catenin accumulates in the cytoplasm, followed by translocation to the nuclei, serving as transcription factors through binding to the T-cell factor/lymphocyte enhancer factor (TCF/LEF) family members (Rubinfeld et al., 1996; Polakis, 2000) . In the absence of Wnt signaling, b-catenin is associated with a cytoplasmic complex containing the adenomatous polyposis coli (APC) protein, the glycogen synthase kinase-3b (GSK-3b), and axin (Su et al., 1993; Yost et al., 1996; Hayashi et al., 1997; Sakanaka et al., 1998; Sakanaka and Williams, 1999) . In this complex, GSK3b constitutively phosphorylates b-catenin at serine or threonine residues in exon 3, and the phosphorylated b-catenin is degraded through the ubiquitinationproteosome pathway (Rubinfeld et al., 1996; Liu et al., 1999) .
Genetic mutations of the genes encoding the components of the Wnt signaling pathway have been identified in various types of human cancers, including the two tumor suppressor genes, APC and AXIN. Somatic mutations of the APC gene have been found in more than 80% of sporadic colorectal carcinomas and the AXIN mutations in about 10% of hepatocellular carcinomas (Kinzler and Vogelstein, 1996; Taniguchi et al., 2002) . Mutation of either APC or AXIN causes constitutive stabilization of the wild-type b-catenin protein, which upregulates downstream genes including c-MYC and cyclin D1 Tetsu and McCormick, 1999) . Meanwhile, b-catenin can undergo mutation to act as a dominant oncogene. Mutations or deletions in exon 3 of b-catenin, which abrogate the phosphorylation sites for its degradation, have been found in many human cancers including colon, liver, skin, and endometrium cancers (Morin et al., 1997; Rubinfeld et al., 1997; Fukuchi et al., 1998; Iwao et al., 1998; Miyoshi et al., 1998) . We also identified four of 166 lung cancers and one lung blastoma with activated mutation of the b-catenin gene (Shigemitsu et al., 2001) .
Besides the growth-stimulating function, apoptosis has recently been proposed as another important function of b-catenin under specific conditions, since the Armadillo-TCF signaling in Drosophila has been shown to induce apoptosis in the developing retinal neuron (Ahmed et al., 1998) . Hasegawa et al. (2002) also found that conditional targeting of APC in the neural crest of mice caused massive apoptosis of cephalic and cardiac neural crest cells, which were observed exclusively in the regions where intracellular b-catenin accumulated. Meanwhile, Kim et al. (2000) observed apoptosis in the NIH 3T3 fibroblasts and several carcinoma cell lines, when transfected with b-catenin. They further suggested that the b-catenin-induced apoptosis was independent of its transactivation function with LEF-1 or the involvement of major G1 cellcycle regulators (Kim et al., 2000) . Thus, several pieces of evidence indicate that the b-catenin accumulation can induce apoptosis under specific conditions during both development and carcinogenesis.
The loss of heterozygosity (LOH) of chromosome 3p is thought to be a critical event in the pathogenesis of various types of human cancers. Especially, the 3p21.3 region undergoes allele loss in 77% of primary lung cancers and 49% of preneoplastic or normal epithelial samples of the smoking-damaged lung (Wistuba et al., 2000) . Although the number of studies is limited because of its infrequent occurrence, malignant mesotheliomas also show frequent LOH at chromosome 3p21 (Lu et al., 1994) . In a previous study, we also demonstrated that a malignant mesothelioma cell line, NCI-H28, has a homozygous deletion at 3p21.3 containing the b-catenin gene (CTNNB1) (Shigemitsu et al., 2001) . With the genomic cloning analysis, we further identified the NCI-H28 homozygous deletion breakpoint site between exons 1 and 2 of the b-catenin gene, and the rearrangement of exon 1 to another 3p region, and found that b-catenin was totally inactivated in the NCI-H28 cells. Hence, it was strongly suggested that the homozygous deletion of the NCI-H28 cells provided a growth advantage for the development of this tumor by inactivation of a possible tumor suppressor gene in this deletion region.
In the present study, to determine whether the bcatenin deletion was one of the crucial events in the development of the NCI-H28 tumor cells, we transfected the wild-type b-catenin, Ser37Cys mutant b-catenin, or C-terminus deletion mutant b-catenin into the NCI-H28 cells, and analysed how the exogenous b-catenin affects the cell growth of the NCI-H28 cells. By using a colony formation assay, we found that the wild-type and Ser37Cys mutant b-catenin induced growth inhibition, whereas the C-terminus deletion mutant did so less potently. Further analyses of Annexin V and terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end-labeling (TUNEL) assays indicated that the growth inhibition occurred because of apoptosis. Thus, our data suggest that b-catenin can act like a tumor suppressor.
Results

Expression of exogenous b-catenin in NCI-H28
To determine whether b-catenin has growth-inhibitory activity in the NCI-H28 cells, we constructed expression vectors of b-catenin, transfected them into the cells, and analysed cell growth. We first constructed three kinds of expression vectors. The wild-type b-catenin (b-CAT-3.1), the Ser37Cys mutant b-catenin as an activated type (b-CAT-S37C-3.1), and the deletion mutant b-catenin missing the C-terminal codons 696-781 (b-CAT-DC-3.1) that binds TCF/LEF but lacks transcription activity ( Figure 1a) . We also constructed the same series of expression vectors tagged with the V5 epitope ( Figure 1a) . Next, we confirmed the expression of exogenous b-catenin products with Western blot analysis after transfection of these constructs into the NCI-H28 cells. All the constructs were confirmed to produce exogenous b-catenin products detected with the anti-bcatenin antibody and/or the anti-V5 antibody (Figure 1b) . We also found that the signal intensities of the Ser37Cys mutant b-catenin were stronger than those of the wild-type b-catenin. Since the Ser37Cys mutant b-catenin was designed to lack a critical GSK-3b phosphoacceptor site, which was important for efficient targeting of ubiquitination and degradation, we suspected that the increase in the protein product was because of increased stability of the proteins.
Localization of exogenous b-catenin in NCI-H28
To determine how these exogenous b-catenin products in the NCI-H28 cells distribute, we performed immunofluorescence analysis after the transfection of the V5-tagged b-catenin constructs, and observed them with a confocal laser scanning microscope. Positive staining of the wild-type b-catenin (b-CAT-V5) was more strongly expressed in the plasma membrane and cytoplasm than in the nucleus with anti-V5 or anti-b-catenin antibody (Figure 2a, b) . In contrast, we observed stronger staining of the activated mutant form (b-CAT-S37C-V5) in the nucleus with a diffuse staining pattern than in the cytoplasm (Figure 2c, d ). The C-terminus deletion mutant (b-CAT-DC-V5) showed positive staining exclusively in the cytoplasm (Figure 2e ). In addition, since anti-b-catenin antibody was raised against the immunogen of C-terminal residues (571-781 amino acids) in bcatenin, the expression of the deletion mutant could be detected with only anti-V5 antibody. We also analysed the subcellular localization of V5-tagged b-catenin in the NCI-H1299 cells, which was shown to express endogenous b-catenin ( Figure 1b ). Immunofluorescence analysis with anti-V5 antibody detected diffuse positive staining of the wild-type bcatenin (b-CAT-V5) in the plasma membrane and cytoplasm (data not shown). The Ser37Cys mutant bcatenin (b-CAT-S37C-V5) also showed the same positive staining pattern as the wild-type b-catenin (data not shown).
Transcription activity of b-catenin in NCI-H28
To determine whether b-catenin products, when expressed in the NCI-H28 cells, act as a transcription activator, we performed a luciferase-reporter assay. The b-catenin constructs were introduced together with pGL3-OT, a positive control reporter plasmid containing TCF-4 binding sites, or with pGL3-OF, a negative control plasmid having mutant TCF-4 binding sites. The ratio of the luciferase activity of the pGL3-OT construct to that of the pGL3-OF construct was shown as the relative TCF activity. The transfection efficiency was normalized using the b-galactosidase activity induced by cotransfected pSV-b-galactosidase control vector as the standard.
Relative TCF activity was stimulated threefold by transfection with the wild-type b-catenin (b-CAT-V5 and b-CAT-3.1) compared to the empty vector controls, respectively ( Figure 3 ). b-CAT-S37C-V5 showed 12-fold the relative TCF activity, and b-CAT-S37C-3.1 21-fold compared to the empty vector controls. Meanwhile, the relative TCF activities of b-CAT-DC-V5 and b-CAT-DC-3.1 were greatly reduced. Similarly, in the NCI-H1299 cells, the relative TCF activities of b-CAT-3.1 and b-CAT-S37C-3.1 were 17-and 38-fold compared with the empty vector controls [pcDNA3.1( þ )], respectively ( Figure 3 ). b-CAT-DC-3.1 also showed less relative TCF activity than b-CAT-3.1 and b-CAT-S37C-3.1.
Inhibition of colony formation by b-catenin in NCI-H28
To test the growth-inhibitory effect of exogenously expressed b-catenin, we performed a colony formation assay selecting for the neo-gene carried by our expression plasmids. We first transfected b-catenin constructs with a tag into the NCI-H28 cells, selected the transfected cells with G418 for 2 or 3 weeks, and counted the surviving colonies, with the vector control set at 100%. The wild-type b-catenin (b-CAT-V5) and Ser37Cys mutant (b-CAT-S37C-V5) suppressed colony formation of NCI-H28 cells relative to vector control (pcDNA3.1/V5-HisA), (45717 and 43723%, respectively) (Figure 4a ). Although the C-terminus deletion mutant b-catenin (b-CAT-DC-V5) also suppressed colony formation (62720%) compared to the vector control, the suppression was less potent than with the wild-type b-catenin and Ser37Cys mutant ( Figure 4a ). Next, we similarly transfected the b-catenin constructs without a tag into the NCI-H28 cells. The number of The C-terminus deletion mutant b-catenin (b-CAT-DC-3.1) gave much less inhibition than the other b-catenin constructs (Figure 4a ). In the process of colony formation assay, we tried to establish stable cell lines expressing the wild-type bcatenin or Ser37Cys mutant. Although we established seven stable neo-resistant clones that were initially transfected with the wild-type b-catenin construct and eight stable neo-resistant clones with the Ser37Cys mutant, we could not detect the expression of b-catenin product with Western blot analysis (data not shown). These results show that no G418-resistant clones that were continuously replicating could express wild-type or Ser37Cys mutant b-catenin gene.
Finally, we also tested the effect of exogenous bcatenin into the NCI-H1299 cells, which express endogenous b-catenin and also have a homozygous deletion of p53. As expected, the wild-type p53 expression showed a significant suppression of colony formation relative to the vector control (Figure 4a) . However, the wild-type b-catenin (b-CAT-3.1) showed nonsignificant growth inhibition of colonies relative to the vector control (Figure 4a ).
b-catenin-induced apoptosis in NCI-H28
The inhibition of colony formation by b-catenin suggested that it may cause apoptosis in the NCI-H28 cells. To confirm this, we first performed an Annexin V assay, which detects the early stage of apoptosis. To identify the cells that expressed b-catenin, we used pIRES-EGFP vector, which simultaneously expresses EGFP and the b-catenin constructs (Figure 1a) . Among the EGFP-positive cells, we determined the percentage of Annexin V-positive cells ( Figure 5) . Transfection of the NCI-H28 cells with wild-type b-catenin (b-CAT-V5-FP) or Ser37Cys mutant (b-CAT-S37C-V5-FP) resulted in significantly higher percentages of Annexin V-positive cells than the empty pIRES-EGFP vector. Although transfection with C-terminus deletion mutant (b-CAT-DC-V5-FP) also resulted in a higher fraction of Annexin V-positive cells than the empty pIRES-EGFP vector, the effect was less pronounced than with both the wild-type b-catenin and Ser37Cys mutant.
Next, we performed a TUNEL assay, which detects the end stage of apoptosis. To identify the cells that were transfected, pEGFP-F vector was used as a marker plasmid. The NCI-H28 cells transfected with the b-CAT-S37C-3.1 construct showed positive staining of TUNEL in their nucleus, but not with the vector control To determine how b-catenin induced apoptosis in the NCI-H28 cells, we analysed representative genes for alterations that are known to be involved in apoptotic cascades. We first studied the p53 gene with direct sequencing from exons 2-11 covering the entire coding region, but found no mutation. Western blot analysis also detected a p53 product of the expected size, indicating that NCI-H28 cells have a wild-type p53 (data not shown). Meanwhile, we performed PCR analysis for exons 1 and 2 of p16
INK4a and found that NCI-H28 has a homozygous deletion, indicating that the p16
INK4a and p14 ARF tumor suppressor genes are completely inactivated in this cell line (data not shown).
To study whether downstream genes of p53 were induced during apoptosis, we studied Bax and Noxa, which are involved in the p53 apoptotic pathway. However, we did not detect induction of these messages with Northern blot analysis (data not shown). Finally, to determine whether exogenous b-catenin induced its own downstream genes, we performed Northern blot and Western blot analyses for Cyclin D1 and Northern blot analysis for c-MYC, but did not find the difference in their expression levels before and after transfection of b-catenin (data not shown).
Discussion
The present study shows that b-catenin inhibits cell growth of the NCI-H28 mesothelioma cells with a 3p21.3 homozygous deletion containing the b-catenin gene, and that the growth inhibition is associated with induction of apoptosis. Homozygous deletions, while uncommon, are key indicators of the presence of the location of TSGs, and several TSGs have been identified by searching the genes in homozygous deletion regions (Sozzi et al., 1996; Burbee et al., 2001; Dammann et al., 2000) . In malignant mesotheliomas, previous karyotypic studies have documented several recurrent alterations, particularly deletions involving chromosome arms 1p, 3p, 4q, 6q, 9p, 13q, 14q, and 22q (Gibas et al., 1986; Popescu et al., 1988; Tiainen et al., 1988; Flejter et al., 1989; Hagemeijer et al., 1990; Taguchi et al., 1993) . LOH analyses have also demonstrated high frequencies of allelic loss at 1p22, 3p, 4q, 6q, 9p21, and 22q12, and most frequently with 3p, 9p21, and 22q12 (Cheng et al., , 1999 Lu et al., 1994; Lee et al., 1996; Bell et al., 1997; Shivapurkar et al., 1999) .
Although it has been well documented that malignant mesothelioma, as well as other types of human malignancies including lung cancer, shows frequent LOH at multiple loci of chromosome 3p, the target gene at each locus has not been clearly identified. A previous study has shown a common region of deletion within band 3p21, flanked by the loci D3S2 (located at 3p21.1) and THRB (located at 3p24.1-p22), suggesting that 3p21 LOH frequently occurs in malignant mesothelioma, and that one or more putative TSGs at this site contribute to the pathogenesis of this tumor (Lu et al., 1994) . We previously found that the NCI-H28 cell line has a homozygous deletion at 3p21.3, suggesting that the deletion provided a growth advantage for the development of this tumor, and that the deletion region may harbor TSGs (Shigemitsu et al., 2001 ). Since we further demonstrated that b-catenin was completely inactivated in this cell line, we speculated that b-catenin itself could be one of the target genes.
In the present study, we showed that the restoration of b-catenin in the NCI-H28 cells induced significant growth inhibition. Colony formation of the NCI-H28 cells was reduced by 50% after transfection with the wild-type b-catenin, and 60% with the Ser37Cys mutant, against only 20% with the C-terminus deletion mutant compared to the vector control. Also, we were unable to establish any stable expression cell lines of the wild-type or Ser37Cys mutant b-catenin under G418 selection. Finally, the growth inhibition of b-catenin in the NCI-H28 cells was associated with induction of apoptosis, detected by positive staining of Annexin V and TUNEL assays in the transfected cells.
Recently, besides the growth-stimulating function, which has been demonstrated in a variety of human cancers including colon cancer, apoptosis has also been proposed as another important function of b-catenin under specific conditions. Constitutive activation of Armadillo, the Drosophila b-catenin homologue, was found to induce apoptosis in Drosophila retinal neurons (Ahmed et al., 1998) . Overexpressed b-catenin also stimulated apoptosis in COS7 cells (van Gijn et al., 2001) . Hasegawa et al. (2002) found that conditional targeting of APC in the neural crest of mice caused massive apoptosis of cephalic and cardiac neural crest cells, which were observed exclusively in the regions where intracellular b-catenin accumulated. Thus, these studies have suggested that the b-catenin accumulation may play a crucial role in apoptosis during the development of specific organs. Meanwhile, Kim et al. (2000) discovered that the apoptosis was also induced in NIH3T3 fibroblasts and some cancer cell lines. Furthermore, they suggested that b-catenin-induced apoptosis was independent of its transactivation function, and hypothesized that a protein-protein interaction in the cytoplasm was responsible for the induction of apoptosis by overexpressed b-catenin (Kim et al., 2000) . However, the exact mechanism of b-catenin-induced apoptosis remains unclear, and both a direct transcriptional effect and an indirect effect have been proposed by different groups (Ahmed et al., 1998; Zhang et al., 1998; Damalas et al., 1999; Hasegawa et al., 2002; Kim et al., 2000) .
The present investigation suggests that both direct transcriptional effect and indirect effect were likely to be involved in the growth inhibition in the NCI-H28 cells. First, the indirect effect was supported by the finding that the C-terminus deletion mutant also showed apoptosis, although the C-terminus deletion mutant was not localized in the nucleus, and abolished the bcatenin/TCF-4-mediated transactivity. On the other hand, the wild-type and Ser37Cys mutant b-catenin inhibited more colony growth, and induced more apoptotic cells than the C-terminus deletion mutant. Since we found that these constructs, especially Ser37Cys mutant, were also localized intensely in the nucleus as well as the cytoplasm and induced higher activity in the luciferase reporter assay than the Cterminus deletion mutant, we suspected that the direct transcriptional effect was also involved in the induction of apoptosis, explaining why these constructs showed a more significant growth inhibition.
b-catenin has been shown to be an oncogene when mutated in exon 3. Indeed, the analyses of the epithelial malignant tumors including colon, liver, skin, and endometrium cancers have revealed a number of mutations in exon 3 (Morin et al, 1997; Rubinfeld et al, 1997; Fukuchi et al., 1998; Iwao et al., 1998; Miyoshi et al., 1998) . We previously found such activated mutations in a subset of primary lung cancers and established lung cancer cell lines (Shigemitsu et al., 2001) . Others have also shown constitutive TCF transcriptional activity in another b-catenin-mutated lung cancer cell line (Sunaga et al., 2001) . In this study, we found that an NSCLC cell line, NCI-HI299, expressing endogenous wild-type b-catenin was not inhibited in colony formation assay by transfection with the wild-type b-catenin, although more exogenous bcatenin was identified and higher relative TCF activity was observed than in the NCI-H28 cells. A possible reason why b-catenin had a growth-inhibitory property in the NCI-H28 cells is that this cell line was a mesodermally derived tumor, originating from mesothelial cells of the pleural cavity. Induction of apoptosis by b-catenin inhibits mesothelioma growth N Usami et al b-catenin during the development of some non-epithelial organs may also suggest this idea (Ahmed et al., 1998; Hasegawa et al., 2002) . Thus, in contrast to the epithelial malignant tumors, b-catenin could conceivably play different roles in the tumors derived from nonepithelial cells. In this sense, the NCI-H28 cell line would also be a good model to elucidate how apoptosis is induced in such types of cells.
Several issues require further clarification. First, we could not detect whether the homozygous deletion occurred in the patient's body because of the lack of primary tumor specimens. Second, another gene besides b-catenin existing in the deleted region could possibly be the target. To clarify this, we are currently identifying and analysing several genes located in this deletion region. Third, the mechanism by which b-catenin induced apoptosis in the NCI-H28 cells has not been clarified well in the present study. We used Northern blot analyses to determine whether b-catenin induced expression of its downstream genes, Cyclin D1 and c-MYC, but found no significant changes. Although NCI-H28 has a wild-type p53, the p16
INK4a gene locus was shown to be homozygously deleted, indicating that both the p16
INK4a and p14 ARF tumor suppressor genes are completely inactivated in this cell line. Since p14 ARF is one of the major regulatory molecules of p53 via inhibition of HDM2 (mdm2 in mice), this result suggested that the p53 apoptotic cascade is altered in NCI-H28. In addition, we did not detect induction of the downstream genes of p53 such as Bax and Noxa after transfection of b-catenin. Thus, these results may suggest that the apoptosis induced in the NCI-H28 cells by b-catenin was not induced in a c-MYC-or p53-dependent manner. Nevertheless, since the differences in the expression levels were studied using the whole cells with transient transfection, and the transfection efficiency was significantly low in the NCI-H28 cells, it is still possible that any induction of the downstream genes might simply be undetectable with the assays we employed. Therefore, in future, cells undergoing apoptosis should be analysed individually for each gene induction.
In conclusion, our data indicated that b-catenin inhibits cell growth of the NCI-H28 cells with a 3p21.3 homozygous deletion via induction of apoptosis. Our study suggests that b-catenin not only acts as a wellknown, positive growth-stimulating factor, yet also paradoxically serves as a potential growth suppressor in some types of human cells.
Materials and methods
Cell lines and culture conditions
NCI-H28 (CRL5820), a malignant mesothelioma cell line, was purchased from the American Type Culture Collection (ATCC) (Rockville, MD, USA). NCI-H1299, a non-small cell lung cancer cell line, the kind gift of Dr Gazdar, was shown to contain a homozygous deletion of p53 (Chen et al., 1993) . These cell lines were grown in RPMI-1640 supplemented with 10% fetal bovine serum and 1 Â antibiotic-antimycotic at 371C in a humidified incubator with 5% CO 2 .
Plasmid construction
The former half of the 1.2 kb region of b-catenin cDNA encoding the protein-translating region was amplified with PCR using cDNA extracted from normal lung and digested at a BamHI site engineered into the 5 0 oligonucleotide and an endogenous EcoRI site. The latter half of the 1.1 kb region of b-catenin cDNA amplified with PCR was digested at an endogenous EcoRI site and an XbaI site engineered into the 3 0 oligonucleotide. With the ligation of both fragments, the total 2.3 kb fragment containing the entire coding region was constructed into the BamHI and XbaI sites of the pcDNA3.1( þ ) (V790-20, Invitrogen, Carlsbad, CA, USA) and pcDNA3.1/V5-HisA (V810-20, Invitrogen). They were named b-CAT-3.1 and b-CAT-V5, respectively. Mutant bcatenin cDNAs were amplified with RT-PCR using RNA from a lung blastoma tumor with Ser to Cys substitution at codon 37 (Shigemitsu et al., 2001) . They were also cloned into the BamHI and XbaI sites of pcDNA3.1( þ ) and pcDNA3.1/V5-HisA, which were named b-CAT-S37C-3.1 and b-CAT-S37C-V5, respectively. The C-terminus deletion mutant b-catenin (b-CAT-DC-3.1 and b-CAT-DC-V5), which lack the last 86 amino acids, were constructed by the PCR technique. All constructs had their sequences confirmed through the PCR-manipulated regions. To select transiently transfected cells, we purchased pIRES-EGFP vector (6029-1, Clontech, CA, USA), and each insert of the b-CAT-V5, b-CAT-S37C-V5, and b-CAT-DC-V5 digested with BamHI and PmeI was cloned into the BglII and SmaI sites of pIRES-EGFP. These constructs were named b-CAT-V5-FP, b-CAT-S37C-V5-FP, and b-CAT-DC-V5-FP, respectively. We also purchased pEGFP-F vector (6074-1, Clontech) as a cotransfection marker. Primers and conditions are available on request.
Transfection and colony formation assay
Cells were transfected with LipofectAMINE PLUS reagent (10964-013, Invitrogen). For colony formation assay, 4 Â 10 5 cells were seeded into six-well plates a day before transfection, which was done according to the manufacturer's instructions. After transfection, cells were trypsinized, replated, and cultured in 600 mg/ml G418 (G7034, Sigma, St Louis, MO, USA) supplemented medium (RPMI 1640 and 10% fetal bovine serum) for 2 or 3 weeks. The number of G418-resistant colonies were counted after staining with methylene blue in ethanol/H 2 O (50/50%). The surviving colonies of vector control were set at 100%. The data represent the mean 7s.d. of five independent experiments, each carried out in triplicate plates and with two independently prepared constructs.
Western blot analysis
Preparation of total cell lysates and Western blotting were performed as described previously (Sekido et al., 2002) . In brief, subconfluently growing cells were rinsed twice with phosphate-buffered saline (PBS), lysed in sodium dodecyl sulfate (SDS) sample buffer (62.5 mm Tris pH 6.8, 2% SDS, 2% 2-mercaptoethanol, 10% glycerol), and homogenized. Total cell lysate (15 mg) protein was subjected to SDSpolyacrylamide gel electrophoresis and transferred to PVDF membranes (ISEQ00010, Millipore, Bedford, MA, USA). Following blocking with 5% nonfat dry milk, the filters were incubated with a 1 : 1000 dilution of the anti-b-catenin antibody (C19220, Pharmingen/Transduction laboratories, San Diego, CA, USA), a 1 : 5000 dilution of the anti-V5 antibody (46-0705, Invitrogen), a 1 : 1000 dilution of the antip53 antibody (NCL-p53-DO7, Novocastra laboratories, New- 
Luciferase assay
The pGL3-OT and pGL3-OF constructs, improved versions of TOPFLASH and FOPFLASH, the kind gift of Dr Vogelstein, contain a luciferase reporter under the control of consensus TCF-4 binding sites and mutated TCF-4 binding sites, respectively. Cells are cotransfected with pGL3-OT or pGL3-OF luciferase reporters and the b-catenin expression vectors. The pSV-b-galactosidase control vector (E1081, Promega, Madison, WI, USA) was also cotransfected in each case to measure the transfection efficiency. b-galactosidase activity was measured with the b-Galactosidase Enzyme Assay System (E2000, Promega). Luciferase assays were performed using the Luciferase Assay System (E1500, Promega).
Annexin V staining
The Annexin V-Biotin Apoptosis Detection Kit (BV-K109-3, MBL, Nagoya, Japan) was used for the Annexin V staining. Cells (0.5 Â 10 5 ) were plated on cover glasses in 24-well plates the day before transfection. At 24 h after transfection with b-CAT-V5-FP, b-CAT-S37C-V5-FP, or b-CAT-DC-V5-FP, cells were gently washed once with 1x binding buffer and incubated with Annexin V-biotin for 5 min at room temperature. Then they were fixed with 4% paraformaldehyde in PBS for 5 min and washed with PBS, and incubation was performed with streptavidin-Alexa 568 (S-11226, Molecular Probes, Netherlands). After staining, the cover glasses were inverted on a drop of mounting medium (434980, Shandon, Pittsburgh, PA, USA) on slide glasses and examined.
TUNEL assay
For the TUNEL assay, we used the in situ cell death detection kit (2156792, Roche, Mannheim, Germany) . At 48 h after cotransfection with no tagged b-catenin constructs and pEGFP-F vector as a cotransfection marker, the cells were fixed with 4% paraformaldehyde in PBS, rinsed with PBS, and incubated in permealization solution (0.1% Triton X-100, 0.1% sodium citrate) for 2 min at 41C. Cells were then rinsed with PBS twice and incubated with TUNEL reaction mixture for 1 h at 371C in the dark. After incubation, the cells were rinsed with PBS three times and analysed under a confocal laser scanning microscope.
Mutational analysis
For p53 mutation, direct sequencing were performed for exons 2-11 using genomic DNA to cover the entire coding frame of p53. Primers used were described previously (Sekido et al., 2002) . For p16 mutation, PCR of p16 was performed using a primer set of p16-1S, 5
0 -CGGAGAGGGGGAGAGCAG-3 0 , and p16-1AS, 5
0 -TCCCCTTTTTCCGGAGAATCG-3 0 , for exon 1, and a primer set of p16-2S, 5
0 -GCTCTACA-CAAGCTTCCTTTCC-3 0 , and p16-2AS, 5 0 -GGGCTGAA-CTTTCTGTGCTGG-3 0 , for exon 2.
Northern blot analysis
Northern blot analysis was performed as described previously (Shigemitsu et al., 2001) . The DNA probes used were cyclin D1 cDNA probe (888 bp) synthesized by RT-PCR with a primer set of cyclin D1-S1 HindIII, 5 0 -AGCAAGCTTATGGAA-CACCAGCTCCTGTG-3 0 , and cyclin D1-AS2 Bam, 5 0 -AGCGGATCCTCAGATGTCCACGTCCCGCA-3 0 , c-MYC cDNA probe (1320 bp) synthesized with a primer set of c-myc CDS S1, 5 0 -ATGCCCCTCAACGTTAGCTT-3 0 , and c-myc AS1320, 5 0 -TTACGCACAAGAGTTCCGTA-3 0 , Bax cDNA probe (360 bp) synthesized with a primer set of BAX-S, 5 0 -CACCAGCTCTGAGCAGATCA-3 0 , and BAX-AS, 5 0 -AT-CAGTTCCGGCACCTTGGT-3 0 , and Noxa cDNA probe (280 bp) synthesized with a primer set of Noxa CDS-S, 5 0 -CTGTCCGAGGTGCTCCAGTT-3 0 , and Noxa CDS-AS, 5 0 -AACTCTTTTGAAGGAGTCCC-3 0 .
